Login
Super Investors ARCH Venture Management, LLC
AV

ARCH Venture Management, LLC

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$1.61B
Positions
17
Quarter ended
September 30, 2026
Filed
November 16, 2026

Reported portfolio value by quarter (28 quarters reported)

$1.61B $20M
Q4 18 Q2 20 Q4 22 Q2 24 Q4 25 Q3 26

$100M in Q4 2018 → $1.61B now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
K Kardigan Inc 13.8% New 15,042,036 $222M
PM Parabilis Medicines Inc 12.8% Unchanged 6,412,780 $207M
Vir Biotechnology Inc 8.8% Unchanged 12,694,163 $142M
Sana Biotechnology Inc 8.3% New 45,860,681 $134M
Seaport Therapeutics Inc 7.9% Unchanged 6,294,951 $127M
Rapport Therapeutics Inc 7.8% Unchanged 3,728,738 $125M
SR Scholar Rock Hldg Corp 7.0% New 2,345,711 $113M
Maze Therapeutics Inc 6.9% Unchanged 4,120,053 $112M
Beam Therapeutics Inc 6.9% Unchanged 4,540,132 $111M
Erasca Inc 6.4% Unchanged 7,091,557 $104M
908 Devices Inc 4.4% New 5,725,045 $70.6M
Prime Medicine Inc 3.5% New 18,486,894 $56.5M
Lyell Immunopharma Inc 2.0% Unchanged 3,247,162 $31.8M
Generate Biomedicines Inc 1.8% Unchanged 1,944,426 $29.2M
Neumora Therapeutics Inc. 1.3% New 33,847,838 $20.2M
Boundless Bio Inc 0.4% Unchanged 2,694,095 $6.76M
Gossamer Bio Inc 0.1% New 100,698 $1.19M

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q3 2026

quarter ended September 30, 2026 · filed November 16, 2026

Company Action Shares changed Value of change % of portfolio
K Kardigan Inc New +15,042,036 +$222M 13.8%
Sana Biotechnology Inc New +45,860,681 +$134M 8.3%
SR Scholar Rock Hldg Corp New +2,345,711 +$113M 7.0%
908 Devices Inc New +5,725,045 +$70.6M 4.4%
Prime Medicine Inc New +18,486,894 +$56.5M 3.5%
Neumora Therapeutics Inc. New +33,847,838 +$20.2M 1.3%
10x Genomics Inc Exited −217,834 −$8.35M —
Gossamer Bio Inc Exited −8,055,916 −$1.33M —
Gossamer Bio Inc New +100,698 +$1.19M 0.1%

Q2 2026

quarter ended June 30, 2026 · filed August 14, 2026

Company Action Shares changed Value of change % of portfolio
PM Parabilis Medicines Inc New +6,412,780 +$176M 16.0%
Seaport Therapeutics Inc New +6,294,951 +$137M 12.4%
Boundless Bio Inc New +2,694,095 +$6.74M 0.6%
Vir Biotechnology Inc Trimmed −222,500 −$2.27M 11.8%
Q32 Bio Inc Exited −320,482 −$2.06M —

Q1 2026

quarter ended March 31, 2026 · filed May 15, 2026

Company Action Shares changed Value of change % of portfolio
Erasca Inc Trimmed −3,963,997 −$64.1M 16.9%
Generate Biomedicines Inc New +1,944,426 +$24.3M 3.6%
10x Genomics Inc Trimmed −519,705 −$11M 0.7%
Lyell Immunopharma Inc Added +488,090 +$9.79M 9.6%

Q4 2025

quarter ended December 31, 2025 · filed February 17, 2026

Company Action Shares changed Value of change % of portfolio
10x Genomics Inc. New +737,539 +$12M 1.8%
Cero Therapeutics Holdings Inc. Exited −22,389 −$114K —

Q3 2025

quarter ended September 30, 2025 · filed November 14, 2025

Company Action Shares changed Value of change % of portfolio
Verve Therapeutics Inc. Exited −2,008,809 −$22.6M —
Lyell Immunopharma Inc. Added +938,438 +$15.2M 9.1%
Unity Biotechnology Inc. Exited −1,004,817 −$386K —

Q2 2025

quarter ended June 30, 2025 · filed August 14, 2025

Company Action Shares changed Value of change % of portfolio
Vir Biotechnology Inc. New +12,916,663 +$65.1M 21.8%
Lyell Immunopharma Inc. New +1,820,634 +$16.1M 5.4%
Cero Therapeutics Holdings Inc. New +22,389 +$216K 0.1%
Cero Therapeutics Holdings, Inc. Exited −22,102 −$16.1K —

Q1 2025

quarter ended March 31, 2025 · filed May 15, 2025

Company Action Shares changed Value of change % of portfolio
Maze Therapeutics, Inc. New +4,120,053 +$45.4M 22.0%
Singular Genomics Systems, Inc. Exited −126,630 −$2.46M —
Cero Therapeutics Holdings, Inc. Exited −9,393,561 −$564K —
Cero Therapeutics Holdings, Inc. New +22,102 +$16.1K —

Q4 2024

quarter ended December 31, 2024 · filed February 14, 2025

Company Action Shares changed Value of change % of portfolio
Beam Therapeutics Inc. Trimmed −294,521 −$7.3M 48.9%
Cero Therapeutics Holdings, Inc. Added +7,949,265 +$477K 0.2%

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support